Insulet
PODD
NZ$495.89
Share price
-0.19%
Change (1 day)
54.11%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$2.79 Billion
According to Insulet's latest financial reports the company's total debt is NZ$2.79 Billion. A company’s total debt is the sum of all current and non-current debts.
Insulet - Total debt on balance sheet (from 2005 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | NZ$2.46 B | 10.26% |
| 2023-12-31 | NZ$2.23 B | 1.4% |
| 2022-12-31 | NZ$2.20 B | 18.38% |
| 2021-12-31 | NZ$1.86 B | 27.04% |
| 2020-12-31 | NZ$1.46 B | 11.36% |
| 2019-12-31 | NZ$1.31 B | 49.38% |
| 2018-12-31 | NZ$0.88 B | 10.71% |
| 2017-12-31 | NZ$0.79 B | 65.94% |
| 2016-12-31 | NZ$0.48 B | 85.25% |
| 2015-12-31 | NZ$0.25 B | 19.76% |
| 2014-12-31 | NZ$0.21 B | 46.24% |
| 2013-12-31 | NZ$0.14 B | 3.09% |
| 2012-12-31 | NZ$0.14 B | 3.28% |
| 2011-12-31 | NZ$0.13 B | 54.53% |
| 2010-12-31 | NZ$89.99 M | -32.6% |
| 2009-12-31 | NZ$0.13 B | 28.77% |
| 2008-12-31 | NZ$0.10 B | 197.73% |
| 2007-12-31 | NZ$34.82 M | -16.04% |
| 2006-12-31 | NZ$41.47 M | 189.86% |
| 2005-12-31 | NZ$14.31 M | 92727.7% |
| 2004-12-31 | NZ$0.01 M | -8.9% |
| 2003-12-31 | NZ$0.01 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 ICU Medical
ICUI | NZ$2.63 B | -5.60% | 🇺🇸 USA |
 Tandem Diabetes Care
TNDM | NZ$0.81 B | -70.91% | 🇺🇸 USA |
 DexCom DXCM | NZ$4.25 B | 52.37% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$86.06 B | 2,981.99% | 🇺🇸 USA |
 Abbott Laboratories ABT | NZ$21.81 B | 681.05% | 🇺🇸 USA |
 Medtronic MDT | NZ$43.82 B | 1,469.36% | 🇮🇪 Ireland |
 Eli Lilly LLY | NZ$63.44 B | 2,171.79% | 🇺🇸 USA |